Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 nov. 2021 12h30 HE | Source: Vivacitas Oncology Inc

Vivacitas Oncology Announces Additions to Leadership Team and Board

WALNUT CREEK, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company") is pleased to announce the addition of Mark Suseck as new Director and Chief Executive...
22 nov. 2021 12h30 HE | Source: Vivacitas Oncology Inc

Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference

WALNUT CREEK, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held oncology company focused on tough-to-treat cancers, will present its lead development candidate,...
18 nov. 2021 08h00 HE | Source: Vivacitas Oncology Inc

Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-Oncology Annual Conference

WALNUT CREEK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, a privately-held oncology company focused on tough-to-treat cancers, and Image Analysis Group (IAG), a premier...